The AOP was developed to offer an insight into the molecular mechanism of PXR mediated hypercholesterolemia, since the mechanisms of drug- and chemical-induced hypercholesterolemia are poorly understood. The gene discussed is NR1I2; the disease is Hypercholesterolemia.